We found that only the core methyltransferase writer METTL3 and reader YTHDF1 were considerably increased in HCC patient samples with BM in comparison with samples from non-bone metastasis or without metastasis (Fig. 1A and Supplementary Table 3). The gene discussed is METTL3; the disease is hepatocellular carcinoma.